» Articles » PMID: 21030291

Chemoenzymatic Methods for Site-specific Protein Modification

Overview
Publisher Elsevier
Specialty Biochemistry
Date 2010 Oct 30
PMID 21030291
Citations 37
Authors
Affiliations
Soon will be listed here.
Abstract

In the past decade, numerous chemical technologies have been developed to allow the site-specific post-translational modification of proteins. Traditionally covalent chemical protein modification has been accomplished by the attachment of synthetic groups to nucleophilic amino acids on protein surfaces. These chemistries, however, are rarely sufficiently selective to distinguish one residue within a literal sea of chemical functionality. One solution to this problem is to introduce a unique chemical handle into the target protein that is orthogonal to the remainder of the proteome. In practice, this handle can be a novel peptide sequence, which forms a 'tag' that is selectively and irreversibly modified by enzymes. Furthermore, if the enzymes can tolerate substrate analogs, it becomes possible to engineer chemically modified proteins in a site-specific fashion. This review details the significant progress in creating techniques for the chemoenzymatic generation of protein-small molecule constructs and provides examples of novel applications of these methodologies.

Citing Articles

Activity-based directed evolution of a membrane editor in mammalian cells.

Tei R, Bagde S, Fromme J, Baskin J Nat Chem. 2023; 15(7):1030-1039.

PMID: 37217787 PMC: 10525039. DOI: 10.1038/s41557-023-01214-0.


Identification of HPV16 E1 and E2-specific T cells in the oropharyngeal cancer tumor microenvironment.

McInnis C, Bhatia S, Vijaykumar B, Tian Q, Sun Y, Leistritz-Edwards D J Immunother Cancer. 2023; 11(3.

PMID: 36990508 PMC: 10069587. DOI: 10.1136/jitc-2023-006721.


Unraveling protein dynamics to understand the brain - the next molecular frontier.

Brewer K, Shi S, Wyss-Coray T Mol Neurodegener. 2022; 17(1):45.

PMID: 35717317 PMC: 9206758. DOI: 10.1186/s13024-022-00546-8.


Drug Conjugation via Maleimide-Thiol Chemistry Does Not Affect Targeting Properties of Cysteine-Containing Anti-FGFR1 Peptibodies.

Jendryczko K, Rzeszotko J, Krzyscik M, Kocyla A, Szymczyk J, Otlewski J Mol Pharm. 2022; 19(5):1422-1433.

PMID: 35389227 PMC: 9066409. DOI: 10.1021/acs.molpharmaceut.1c00946.


Broadening the Scope of the Flavin-Tag Method by Improving Flavin Incorporation and Incorporating Flavin Analogs.

Tong Y, Loonstra M, Fraaije M Chembiochem. 2022; 23(11):e202200144.

PMID: 35373879 PMC: 9400968. DOI: 10.1002/cbic.202200144.


References
1.
Gamblin D, Scanlan E, Davis B . Glycoprotein synthesis: an update. Chem Rev. 2008; 109(1):131-63. DOI: 10.1021/cr078291i. View

2.
Fontana A, Spolaore B, Mero A, Veronese F . Site-specific modification and PEGylation of pharmaceutical proteins mediated by transglutaminase. Adv Drug Deliv Rev. 2007; 60(1):13-28. DOI: 10.1016/j.addr.2007.06.015. View

3.
Carrico I, Carlson B, Bertozzi C . Introducing genetically encoded aldehydes into proteins. Nat Chem Biol. 2007; 3(6):321-2. DOI: 10.1038/nchembio878. View

4.
Keppler A, Gendreizig S, Gronemeyer T, Pick H, Vogel H, Johnsson K . A general method for the covalent labeling of fusion proteins with small molecules in vivo. Nat Biotechnol. 2002; 21(1):86-9. DOI: 10.1038/nbt765. View

5.
Gautier A, Nakata E, Lukinavicius G, Tan K, Johnsson K . Selective cross-linking of interacting proteins using self-labeling tags. J Am Chem Soc. 2009; 131(49):17954-62. DOI: 10.1021/ja907818q. View